Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CHANGES TO NOMINATION COMMITTEE FOR SAS AB (PUBL)

SAS AB has been informed that the Danish government through the Ministry of Finance has decided to make a change, which means that the current member Peder Lundquist is replaced by Adrian Lübbert in the Nomination Committee for SAS AB. Adrian Lübbert is Head of Division, Competition, State-owned enterprises and utilities at the Ministry of Finance. Following the change, the Nomination Committee consists of:Carsten Dilling, Chairman of the Board, SAS ABÅsa Mitsell, Swedish Ministry of Enterprise and Innovation, representing the Swedish governmentAdrian Lübbert, Danish Ministry of

Linda Neckmar is proposed as a new board member of EQL Pharma AB for election at the Annual General Meeting on 27 August 2020

Linda Neckar (born 1973) has 25 years of experience from Healthcare and Pharmaceutical industry, in both small and larger companies, where she has held leading positions in scientific business development, marketing and sales, contract negotiation and project management.From 2011 to 2020, Linda was employed at Probi AB, where she worked with marketing and sales, acquisitions, and operations, for a number of years in the executive management team. Earlier in her career, Linda was employed as a business developer at Bioinvent, where she signed technology licensing agreements with Bayer and

Elekta Unity MR-Linac receives clearance by China’s National Medical Products Administration

Introduction of magnetic resonance radiation therapy (MR/RT) expected to transform cancer care in ChinaBEIJING, August 21, 2020 – Elekta (EKTA-B.ST) today announced that the world’s first high-field 1.5T MR radiation therapy system, Elekta Unity, has received clearance from the National Medical Products Administration (NMPA), clearing the technology for clinical use in China. Elekta Unity is a state-of-the art MR-Linac that is setting a new standard for personalized adaptive radiation therapy. Elekta Unity provides the ability to reshape the dose based on daily changes in shape, size and

Moody’s assigns Rikshem rating A3, outlook stable

Rikshem has today received a credit rating A3 with stable outlook from Moody's.- We have for a long time continuously strengthened financially and improved internal governance. Rikshem is a stable company with strong owners and we are now increasing our focus on continuously improving the portfolio's quality and long-term earning capacity. It feels excellent that Moodys, after its extensive analysis of the company, assigns us this rating, says Anette Frumerie, CEO of Rikshem

OssDsign reports successful outcome at 6-month follow-up of clinical study on sinus augmentation

OssDsign AB (publ) today announced positive interim results from a clinical study titled: “Safety and performance of granular calcium phosphate in augmentation of the maxillary sinus floor”. This study represents the first use of OssDsign’s proprietary calcium phosphate material in the oral cavity.As previously communicated, OssDsign has been sponsoring a clinical investigation of the safety and performance of the company’s proprietary calcium phosphate material to support bone growth in augmentation of the maxillary sinus floor. This open evaluation study is being performed on 20

Downturn due to COVID-19 but the Group is standing strong for the future

As expected, the second quarter was affected by COVID-19 in the form of extensive lockdowns across all of society and a historic downturn in the global economy.Group For Beijer Alma, the primary effect was a sharp drop in order bookings and sales across several businesses. Earnings were also impacted by restructuring costs totaling MSEK 22. The Group has successfully addressed developments through a strong, clear focus on cash flow and through measures to reduce our costs, such as the application of furlough schemes in large portions of production. Throughout the spring, we continued to

Visma reaches valuation of US$12.2 billion after new investment

Visma positioned to lead European digitisation European software provider Visma is pleased to announce that Hg, a leading software investor and current majority shareholder of Visma, has agreed to further its investment in the company. Existing investor CPPIB will also acquire additional stakes. Furthermore, global investment firms TPG and Warburg Pincus will become investors in Visma for the first time. TPG manages funds in growth capital, public equity, and other investments, while Warburg Pincus specialises exclusively in private equity and growth investing. Their contributions will

The modern board mill Metsä Board Kyro is celebrating its 150th anniversary

Metsä Board Corporation press release 21.08.2020Metsä Board's Kyro mill will be 150 years old this year, 2020. The wood grinding plant along the Kyröskoski rapids was started up in 1870. Since then, the Kyro mill has manufactured market wood pulp, groundwood, sawn timber, various papers and paperboard for international markets. Today, it is a modern and efficient mill that produces high-quality folding boxboard for Metsä Board, part of Metsä Group.  “Kyro people are proud of their mill. Our staff have always lived with changes and challenging times have been overcome by working together.

Correction: Missing MAR label in previous press release “ Interim report January - June 2020”

Correction: Missing MAR label in previous press release “Interim report January - June 2020” Mekonomen AB (publ) announces a correction of the press release, published today, August 21, 2020, at 07.30 am CET, “Mekonomen AB (publ) Interim Report January-June 2020”The correction relates to the fact that the press release lacked a MAR label with reference to the EU´s Market Abuse Regulation. The following text should have been included in the press release: “This information is such information that Mekonomen AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.

Aspire Global Hosts a Virtual Capital Markets Day on Friday 18 September

Over the past year, Aspire Global  has taken significant strategic steps in order to strengthen its market position. For example, Aspire Global has successfully integrated the game aggregator and game studio Pariplay and expanded its offering to new markets in Europe as well as in the US. However, the iGaming industry is quickly changing. Therefore, Aspire Global wants to showcase how we anticipate the iGaming industry to look like in the coming five years and our strategic choices in order to continue to demonstrate profitable growth.We therefore invite you

New CEO of Brothers

RNB Retail and Brands' Brothers business area changes CEO. Lina Söderqvist, current CEO of Brothers, has chosen to leave Brothers and will be replaced by Brothers' current Deputy CEO/Assortment Director Christopher Englinde. Christopher will take office on September 1, 2020. “Lina Söderqvist has in an excellent way led the work of developing an updated customer-focused strategy for Brothers, and at the beginning of 2020 we saw positive effects of that change. During Brother's corporate reorganization, Lina has also done a very good job of leading the work of change, so that Brothers now

NENT Group extends Nordic rights to Scottish Premiership football

· Viaplay to stream 48 live Scottish Premiership games every season until 2025 · Extended five-year agreement covers entire Nordic region and includes Iceland for first time · NENT Group has rights to show more than 50,000 hours of the world’s best live sporting action every year on its streaming services and TV channels Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has extended its exclusive Nordic rights to Scottish Premiership football until the end of the 2024/2025 season. NENT Group will show 48 Scottish Premiership matches live every

Senzime’s Interim report January – June 2020

Press release: Uppsala, August 21, 2020. Senzime AB’s (publ) Interim report for January – June 2020 is now available on the company’s website  www.senzime.comPM Senzime Interim Report Q2 2020    Financial information for the second quarter 2020 · Net sales amounts to KSEK 1,158 (1,218) · Income after financial items amounts to KSEK -13,342 (-9,153) · Earnings per share before dilution amounts to SEK -0.22 (-0.17) Financial information January-June 2020 · Net sales amounts to KSEK 3,747 (1,603) ·

NeoDynamics AB (publ) Half year report 2020

NeoNavia ready for marketThe English text is an unofficial translation of the Swedish report. Second quarter 2020 · There were no sales during the period. Revenue amounted to SEK 6.263 m (6.328 m) including capitalized costs of SEK 5.787 m (6.328 m). · Loss after tax amounted to SEK -5.516 m (-3.981 m). · Losss per share amounted to SEK -0.18 (-0,26). Half year 2020 · There were no sales during the period. Revenue amounted to SEK 12.531 m (11.748 m), whereof capitalized costs SEK 12.090 m (11.745 m). · Costs for product development was higher than expected. ·

Heliospectra (publ) Half Year Report January-June 2020

(GOTHENBURG, Sweden August 21th 2020)– Heliospectra AB (publ) (North American ADR OTCQB: HLSPY, and Nasdaq First North Growth Market: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents Half Year Report for January-June 2020.  Full report is enclosed to this press release and is also uploaded at www.heliospectra.com  This information was provided for publication the 21st of August 2020 at 08,30 CEST.SUMMARY OF REPORT: SALES AND FINANCIAL

INITIATOR PHARMA: H1 2020 report

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.  Second Quarter (2020-04-01 – 2020-06-30) · Net revenues were TDKK 0 (0) · EBIT was TDKK -3,013 (-3,404) · Earnings per share was DKK –0.13 (-0.15) First Six Months of the Year (2020-01-01 – 2020-06-30) · Net revenues were TDKK 0 (0) · EBIT was TDKK -5,405 (-4,867) · Earnings per share was DKK –0.23 (-0.21) · Cash and bank: TDKK 8,189 (11,501) · Solidity:

Atlas Copco’s SVP Controlling and Finance and CFO Hans Ola Meyer to retire in 2021

Nacka, Sweden, August 21, 2020: Hans Ola Meyer, Atlas Copco’s Senior Vice President Controlling and Finance and CFO, has decided to retire. He will stay on until end of July 2021.Hans Ola Meyer, born 1955, began his Atlas Copco career in 1978. Between 1984 and 1991 he was employed outside the Group. He returned to Atlas Copco in 1991 and has since 1993 been a member of the Group Management."Hans Ola has contributed to Atlas Copco’s success in many ways during his long career,” said Mats Rahmström, President and CEO. “He has been a dedicated leader and with his vast experience and

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q2 2020

"The second quarter was the most uncertain quarter we have ever entered as a listed company. We did not know whether we would see a major revenue drop or be able to escape the financial turmoil caused by COVID-19 without harm. We can now conclude that our journey of growth continued, with a 10 percent sales increase during the quarter for a total of MSEK 36.1 (32.7). We were also able to improve our profitability, and we reached a significant milestone as we for the first time as a listed company achieved a positive net profit of MSEK 0.9 (-0.3) for the group!"Translation from CEO Mårten

The OXE300 has successfully concluded its certification run for EPA and IMO emission test.

OXE Marine AB (“the Company”) has successfully conducted certification run with its OXE300 production engine. All required test reports and supplementary documentation for the EPA application process have been forwarded and received by EPA for their effective handling towards the issuance of certificate for commercial and recreational use. The application is for EPA and IMO (for US flagged vessels). IMO (for international) and RCD will follow later as it is a separate process by DNV-GL. “Developing the engine hardware and software calibration for the successful homologation

Crown Energy AB: Interim Report January-June 2020

Q2 – April-JUNE 2020 ·Revenue amounted to SEK 8,247 thousand (12,492). ·Operating profit amounted to SEK 24 thousand (1,861). ·Net financial items amounted to SEK 19,676 thousand (15,427). ·Unrealised changes in property values amounted to SEK -2,529 thousand (133,974). ·Profit before tax amounted to 17,171 thousand (151,262), and profit after tax amounted to SEK 13,730 thousand (108,572), corresponding to SEK 0.03 (0.23). Half YEAR– JANUARY-JUNE 2020 ·Revenue amounted to 17,355 thousand (25,538). ·Operating profit amounted to SEK -5,826

NRC Group ASA - Appointed to a contract in Norway - NOK 35 million

Statnett SF has appointed NRC Anlegg AS, a company wholly owned by NRC Group ASA, to a contract for ground, foundation and construction work at the terminal/port in Skien. The contract is valued at approximately NOK 35 million. The work will commence in September 2020, and the project is scheduled for completion in January 2021. Closing date for submission of complaints is 10 days from today, and formal contractual signing can take place after this period at the earliest. For further information, please contact: Henning Olsen, CEO of NRC Group, + 47 91 74 15 92. This information

Alzinova announces a delay in the supply of material for the clinical trial due to additional analytical work

Alzinova AB announces today that the manufacture of the drug substance for the Phase 1b clinical trial in Alzheimer's disease patients with the ALZ-101 vaccine has been delayed, as additional analytical work must be performed.As previously disclosed, Alzinova has switched to a new supplier of the drug substance used for the ALZ-101 vaccine. According to plan, a technical batch of non-GMP (Good Manufacturing Practice) drug product was delivered on schedule during the second quarter. The purity of this batch was found to be higher than that of the drug substance produced by the previous

There are no items matching the current filter
There are no more items matching the current filter
Back to top